Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Abraham

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Cardiac Failure|October 1, 1994
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failureW T Abraham, B D Lowes, M White, et al.
Journal of Cardiac Failure|March 27, 2001
Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysisK A Schleman, J A Lindenfeld, B D Lowes, et al.
Journal of Cardiac Failure|May 9, 1998
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failureW T Abraham, B D Lowes, D A Ferguson, et al.
Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.
Journal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.
Heart (British Cardiac Society)|August 14, 2015
Individual patient data network meta-analysis of mortality effects of implantable cardiac devicesB Woods, N Hawkins, S Mealing, et al.
Lancet (London, England)|October 30, 1993
Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyM V Raynolds, M R Bristow, E W Bush, et al.
The American Journal of Cardiology|December 15, 1995
Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathyM White, F Yanowitz, E M Gilbert, et al.
The American Journal of Physiology|December 31, 1997
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancyA B Chapman, S Zamudio, W Woodmansee, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Second- and third-generation beta-blocking drugs in chronic heart failureM R Bristow, W T Abraham, T Yoshikawa, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Cardiac Failure|October 1, 1994
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failureW T Abraham, B D Lowes, M White, et al.
Journal of Cardiac Failure|March 27, 2001
Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysisK A Schleman, J A Lindenfeld, B D Lowes, et al.
Journal of Cardiac Failure|May 9, 1998
Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failureW T Abraham, B D Lowes, D A Ferguson, et al.
Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.
Journal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.
Heart (British Cardiac Society)|August 14, 2015
Individual patient data network meta-analysis of mortality effects of implantable cardiac devicesB Woods, N Hawkins, S Mealing, et al.
Lancet (London, England)|October 30, 1993
Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyM V Raynolds, M R Bristow, E W Bush, et al.
The American Journal of Cardiology|December 15, 1995
Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathyM White, F Yanowitz, E M Gilbert, et al.
The American Journal of Physiology|December 31, 1997
Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancyA B Chapman, S Zamudio, W Woodmansee, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Second- and third-generation beta-blocking drugs in chronic heart failureM R Bristow, W T Abraham, T Yoshikawa, et al.
Pageof 6